U.S. announces anti-malarial drug trial for COVID-19 in Detroit

U.S. Vice President Mike Pence on Sunday announced that anti-malarial drug hydroxychloroquine will be used in a drug trial covering 3,000 patients at a hospital in Detroit, Michigan. 

Pence, who made the announcement at a White House briefing, said the results will be tracked in a formal study and that the U.S. is "more than prepared" to make hydroxychloroquine available to doctors' offices and pharmacies in the Detroit area.

As of early Monday, the U.S. has reported 337,620 confirmed cases of COVID-19 and 9,643 deaths. So far, 17,530 people have recovered from the disease, according to the latest data released by Johns Hopkins University.